Group 1 - The company Beiningmei announced on its interactive platform that some of its infant formula, children's formula, and adult formula product lines are being sold at Pang Donglai in Xuchang [1]

格隆汇8月5日丨贝因美(002570.SZ)在互动平台表示，公司的所有产品都没有涨价，请大家勿信谣不传 谣。我们坚信国家政策红利的本质是惠及民生，企业的责任是让这份温暖真正传递到每个家庭。贝因美 始终坚持初心，让每个家庭都能享受到"货真价实"的育儿支持。 ...

Core Viewpoint - The company Beiningmei (002570.SZ) has announced that some of its infant formula, children's formula, and adult formula product lines are being sold at the Yunchang Pandonglai store in Xuchang [1] Group 1 - The company is expanding its distribution channels by selling products in a new retail location [1] - The product lines mentioned include infant formula, children's formula, and adult formula [1]

格隆汇8月5日丨贝因美(002570.SZ)在互动平台表示，公司主营业务不涉及抗生素相关产品。 ...

Core Viewpoint - The newly announced national childcare subsidy policy allows eligible families to receive up to 3,600 yuan per child annually, which has led to increased consumer enthusiasm, but has coincided with rising prices of infant formula and related products online [1][6][11]. Price Changes in Infant Products - Many brands of infant formula have raised prices recently, with one brand's 810g formula increasing from 342 yuan to 359 yuan, resulting in an additional annual cost of 540 yuan for consumers [3][8]. - Price increases are not limited to infant formula; other baby-related products such as diapers and baby food have also seen price hikes, with some experiencing double-digit increases [3][8]. Online vs. Offline Pricing - Some brands attribute the price increases to the dynamic nature of e-commerce pricing, while offline prices remain stable due to long-term supply contracts with suppliers [4][8]. - A survey revealed that offline prices for these products are often lower than online prices, indicating a disparity in pricing strategies between channels [4][8]. Brand Responses to Price Increases - Several infant formula brands have denied any official price increases, stating that different promotional prices may apply at different times [6][9]. - Brands like Beiyinmei and Yili have claimed that while costs may have risen, their retail prices have not changed, suggesting a disconnect between consumer perceptions and brand communications [6][9]. Impact of Subsidy Policy on Pricing - The introduction of the childcare subsidy is expected to influence consumer behavior, potentially leading families to opt for higher-end products, thereby providing brands with an opportunity to raise prices [9][11]. - The subsidy, while seemingly modest at 300 yuan per month, could significantly impact purchasing decisions in the highly brand-dependent and inelastic baby product market [9][10]. Market Dynamics and Consumer Sentiment - The current price increases appear to be a strategic move by brands to adjust pricing structures following a period of intense price competition in the infant formula market [11][12]. - Although the price hikes have primarily been observed online, the timing of these increases in relation to the subsidy announcement has led to consumer dissatisfaction, as many have not yet received the benefits [11][13].

证券代码：002570 证券简称：贝因美 公告编号：2025-049 贝因美股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）于 2025 年 4 月 29 日召开的第九 届董事会第九次会议审议通过了《关于回购公司股份方案的议案》，公司拟以集 中竞价交易方式回购公司 A 股股票，用于公司未来实施的股权激励或员工持股 计划。本次回购金额不超过人民币 3 亿元（含），不低于人民币 1.5 亿元（含）， 回购价格不超过 9.06 元/股（含）。根据最高回购规模、回购价格上限测算，预 计回购股份数量为 3,311.26 万股，约占公司目前总股本的 3.07%。具体内容详见 公 司 于 2025 年 4 月 30 日 披 露 于 指 定 信 息 披 露 媒 体 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）上的《关于回购公司股份方案暨取得股票回购专项 贷款承诺函的公告》（公告编号：2025-035）。 （1）委托价格不得为公司股票当日交易涨幅限制的价格； （2）不得在深圳证券交易所开盘集合竞 ...

Core Viewpoint - The company faces increased uncertainty in its transformation journey due to the debt crisis of its controlling shareholder and changes in the board of directors [1][3]. Debt Crisis - The controlling shareholder, Zhejiang Xiaobei Damei Holdings Co., applied for pre-restructuring due to liquidity issues and inability to repay debts, which was approved by the court [3][4]. - As of July 23, Xiaobei Damei holds 132.6 million shares of the company, accounting for 12.28% of total shares, with 98.85% of these shares pledged or frozen [3][4]. - The company claims that the pre-restructuring will not significantly impact its daily operations, asserting its independence in business and financial matters [3][4]. Performance Fluctuations - The company's revenue peaked at over 6 billion yuan in 2013 but has since declined, with 2024 revenue reported at 2.773 billion yuan, less than half of its peak [5]. - The company has experienced five years of negative net profit over the past decade, with the highest loss exceeding 1 billion yuan in 2017 [5][6]. - Frequent performance revisions have led to the company being labeled as "A-share face-changing king," with multiple corrections to earnings forecasts and financial reports since 2013 [6]. Transformation Challenges - The company attempted to expand its product positioning to "full lifecycle health management" but faced challenges shortly after this announcement [7]. - The controlling shareholder has been listed as a dishonest executor, and there have been non-operational fund occupations amounting to 47.85 million yuan that were returned within the same year [7]. - The company has diversified into adult milk powder and high-end products, but new business segments account for less than 10% of total revenue as of 2024 [8]. - Factors contributing to the difficulties in transformation include resource dispersion, insufficient investment in core business, and frequent management changes leading to a lack of coherent operational strategies [8].

证券日报网讯8月4日晚间，贝因美（002570）发布公告称，2025年8月4日，公司通过回购专用证券账户 以集中竞价交易方式首次实施回购股份，回购股份数量486，400股，占公司总股本的0.05%。 ...

格隆汇8月4日丨贝因美(002570.SZ)公布，2025年8月4日，公司通过回购专用证券账户以集中竞价交易 方式首次实施回购股份，回购股份数量486,400股，占公司总股本的0.05%，最高成交价为7.21元/股，最 低成交价为7.13元/股，成交总金额为3,483,673.00元（不含交易费用）。 ...

Group 1 - The company announced that as of July 31, 2025, it has not repurchased any shares [2] - For the year 2024, the company's revenue composition is entirely from the infant and child industry, accounting for 100.0% [2]